MedTrace Logo

PrEP SMART Phase I Trial

NCT02895893 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-05-22

No results posted yet for this study

Summary

The goal of this Phase I study is to conduct a proof-of-concept trial of a contingency management (CM) targeting adherence to oral HIV antiretroviral pre-exposure prophylaxis (PrEP) administered via a smartphone-based medication adherence platform (PrEP SMART, "the app").

Conditions

  • At Risk for HIV

Interventions

BEHAVIORAL

PrEP Smart

Men who have sex with men and already prescribed and taking oral PrEP will use an application on their smart phone for 4 weeks.

Sponsors & Collaborators

  • Intelligent Automation, Inc.

    collaborator INDUSTRY

  • Duke University

    lead OTHER

Principal Investigators

  • John Mitchell, Ph.D. · Duke University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-05-04
Completion
2017-05-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02895893 on ClinicalTrials.gov